These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3325250)

  • 1. [Clinical significance of using captopril compounds treating primary hypertension].
    Zhu YC
    Zhonghua Xin Xue Guan Bing Za Zhi; 1987 Jun; 15(3):139-41. PubMed ID: 3325250
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive and hypokalemic effects of isobutyl hydrochlorothiazide alone and in combination with spironolactone.
    Lochaya S; Suvachittanont O; Triyanond K
    J Med Assoc Thai; 1985 Aug; 68(8):399-407. PubMed ID: 3906011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Captopril and diuretics].
    Cremer W
    MMW Munch Med Wochenschr; 1982 Nov; 124(47):1067-9. PubMed ID: 6817123
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of tolerability and antihypertensive efficacy of aceplus mite (captopril (CPT) 50 mg + hydrochlorothiazide (HCTZ) 15 mg): a double-blind study vs. HCTZ in diabetic hypertensive patients. A report on three treatments].
    Santucci A; De Cesaris R; Buoninconti R; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):149-53. PubMed ID: 2678308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension.
    Bénétos A; Laflèche A; Asmar R; Gautier S; Safar A; Safar ME
    J Hum Hypertens; 1996 Feb; 10(2):77-82. PubMed ID: 8867559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination therapy of arterial hypertension].
    von Manteuffel GE; Ebel H; Zehner J
    Med Klin; 1980 Apr; 75(8):297-302. PubMed ID: 6104777
    [No Abstract]   [Full Text] [Related]  

  • 7. [Double-blind controlled study of the therapeutic effectiveness and tolerance of the guabenxan-bemetizid combination as compared with guanethidine-hydrochlorothiazide in arterial hypertension in the aged].
    Silvestrini C; Maini C; Marchesi M; Mueller G
    G Clin Med; 1982 Apr; 63(4):270-8. PubMed ID: 6751915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the efficacy and tolerability of a fixed dose combination of captopril (CPT) 50 mg and hydrochlorothiazide (HCTZ) 15 mg in the elderly].
    Antonicelli R; Raffaelli S; Bossini A; Paciaroni E; Zingaretti P; Botta GF
    Riv Eur Sci Med Farmacol; 1989 Apr; 11(2):155-61. PubMed ID: 2678309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension.
    Dussol B; Moussi-Frances J; Morange S; Somma-Delpero C; Mundler O; Berland Y
    Nephrol Dial Transplant; 2005 Feb; 20(2):349-53. PubMed ID: 15615808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of low-dose captopril on mild to moderate essential hypertension.
    Abe K
    Adv Exp Med Biol; 1989; 247A():49-53. PubMed ID: 2690591
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitors and quality of life: the European trial.
    Hill JF; Bulpitt CJ; Fletcher AE
    J Hypertens Suppl; 1985 Nov; 3(2):S91-4. PubMed ID: 3003305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moderate sodium restriction, angiotensin converting enzyme inhibition, and thiazide diuretic in the management of essential hypertension.
    Singer DR; Markandu ND; Furnival L; Khoshnodi L; MacGregor GA
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S5-7. PubMed ID: 2474103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE inhibitors in mild to moderate hypertension: comparison of lisinopril and captopril administered once daily. French Cooperative Study Group.
    Gosse P; Dallocchio M; Gourgon R
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():23-8. PubMed ID: 2550642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing dosages of captopril and hydrochlorothiazide in the treatment of hypertension: long-term effects metabolic values and intracellular electrolytes.
    Costa FV; Borghi C; Boschi S; Ambrosioni E
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S70-6. PubMed ID: 2580180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intervention trials in the treatment of hypertension. Ongoing studies].
    Berglund G
    Cardiologia; 1984; 29(1-2):63-71. PubMed ID: 6152542
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.